Reported Intake of Selected Micronutrients and Risk of Colorectal Cancer: Results from a Large Population-based Case–control Study in Newfoundland, Labrador and Ontario, Canada

Ph.D. Division of Community Health, Faculty of Medicine, Memorial University of Newfoundland, 300 Prince Philip Drive, St. John's, NL, A1B 3V6, Canada. .
Anticancer research (Impact Factor: 1.83). 02/2012; 32(2):687-96.
Source: PubMed


The impact of micronutrient intake and colorectal cancer (CRC) risk is poorly understood. The objective of this study was to evaluate the associations of selected micronutrients with risk of incident CRC in study participants from Newfoundland, Labrador (NL) and Ontario (ON), Canada.
We conducted a population-based study among 1760 case participants and 2481 age- and sex-matched control participants. Information on diet and other lifestyle factors were measured using a food frequency questionnaire and a personal history questionnaire. Odds ratios (OR) and 95% confidence intervals (CI) were calculated using unconditional logistic regression, controlling for covariables.
Highest compared to lowest quartile intakes of certain micronutrients were associated with lower risk of CRC, including: calcium (from food and supplements (FS), OR=0.59; 95% CI=0.45-0.77, and from food only (FO): OR=0.76, 95% CI=0.59-0.97), vitamin C (FS:OR=0.67; 95%CI:0.51-0.88), vitamin D (FS: OR=0.73; 95% CI: 0.57-0.94, FO: OR=0.79, 95% CI=0.62-1.00), riboflavin (FS: OR=0.61; 95% CI=0.47-0.78, and folate (FS: OR=0.72; 95% CI=0.56-0.92). Higher risk of CRC was observed for iron intake (highest versus lowest quintiles: OR=1.34, 95% CI=1.01-1.78).
This study presents evidence that dietary intake of calcium, vitamin D, vitamin C, riboflavin and folate are associated with a lower risk of incident CRC and that dietary intake of iron may be associated with a higher risk of the disease.

Download full-text


Available from: Peizhong Peter Wang, Oct 03, 2015
21 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objectives: Folate supplementation may be associated with an increased risk of developing several types of cancer and a derangement of immune function. Among the latter, Natural killer (NK) cells are involved in non-MHC-restricted natural immunity against malignant target cells. Abnormalities in NK cell number or function have been associated with a higher cancer risk. The aim of this study was to study in vitro the possible effect of different concentrations of 5-methyltetrahydrofolic acid (5-MTHF) or folic acid on NK cell cytotoxic function, and expression of the stimulatory and inhibitory receptors KIRDL4, KIRDL3, and NKG2D. Methods: Volunteer-derived peripheral mononuclear cells (PBMC) and highly enriched NK cells (95% CD56+ CD16+) were grown in folic acid free-RPMI 1640, supplemented either with folic acid or 5-MTHF (15-100 nM) during 72 h to 96 h. Results: No differences in the cytolytic activity of PBMC and enriched NK cells were observed. After 96 h of in vitro culture without folate or supplemented with FA or 5-MTHF (30 or 100 nM), there were no changes in the percentage of HPNK receptor-positive cells. Conclusions: Our data indicate that a high dose of 5-MTHF or folic acid does not influence NK cell function in vitro.
    Nutrition 01/2013; 29(5). DOI:10.1016/j.nut.2012.10.006 · 2.93 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: To examine the association between dietary patterns and colorectal cancer (CRC) survival. Cohort study. A familial CRC registry in Newfoundland. 529 newly diagnosed CRC patients from Newfoundland. They were recruited from 1999 to 2003 and followed up until April 2010. Participants reported their dietary intake using a food frequency questionnaire. Dietary patterns were identified with factor analysis. Multivariable Cox proportional hazards models were employed to estimate HR and 95% CI for association of dietary patterns with CRC recurrence and death from all causes, after controlling for covariates. Disease-free survival (DFS) among CRC patients was significantly worsened among patients with a high processed meat dietary pattern (the highest vs the lowest quartile HR 1.82, 95% CI 1.07 to 3.09). No associations were observed with the prudent vegetable or the high-sugar patterns and DFS. The association between the processed meat pattern and DFS was restricted to patients diagnosed with colon cancer (the highest vs the lowest quartile: HR 2.29, 95% CI 1.19 to 4.40) whereas the relationship between overall survival (OS) and this pattern was observed among patients with colon cancer only (the highest vs the lowest quartile: HR 2.13, 95% CI 1.03 to 4.43). Potential effect modification was noted for sex (p value for interaction 0.04, HR 3.85 for women and 1.22 for men). The processed meat dietary pattern prior to diagnosis is associated with higher risk of tumour recurrence, metastasis and death among patients with CRC.
    BMJ Open 01/2013; 3(2). DOI:10.1136/bmjopen-2012-002270 · 2.27 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Iron has been suggested as a risk factor for different types of cancer mainly due to its pro-oxidant activity which can lead to oxidative DNA damage. Furthermore, subjects with hemochromatosis or iron overload have been shown to have a higher risk of developing liver cancer. We have systematically reviewed 59 epidemiological studies, published between 1995 and 2012, reporting information on total iron, dietary iron, heme iron and biomarkers of iron status and cancer risk. Furthermore we conducted meta-analysis for colorectal (RR=1.08, 95%CI: 1.00-1.17), colon (RR=1.12, 95%CI: 1.03-1.22), breast (RR=1.03, 95%CI: 0.97-1.09) and lung cancer (RR=1.12, 95%CI: 0.98-1.29), for an increase of 1 mg/day of heme iron intake. Globally, based on the systematic review and the meta-analysis results, a higher intake of heme iron has shown a tendency towards a positive association with cancer risk. Unexpectedly, evidence regarding high levels of biomarkers of iron stores (mostly with serum ferritin) suggests a negative effect towards cancer risk. More prospective studies combining research on dietary iron intake, iron biomarkers, genetic susceptibility and other relevant factors need to be conducted in order to clarify these contradictory findings and better understand the role of iron in cancer development.
    Cancer Epidemiology Biomarkers & Prevention 11/2013; 88(5). DOI:10.1158/1055-9965.EPI-13-0733 · 4.13 Impact Factor
Show more